Dementia is the 6th leading cause of death in the U.S. and there hasn't been a lot of hope with prevention or treatment. However, recently published evidence suggests the shingles vaccine may delay its onset.
 
The GameChanger
Several studies suggest a delay in onset of dementia with the recombinant shingles vaccine.

Host
Jen Moulton, BSPharm
President, CEimpact

Guest
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Reference
The recombinant shingles vaccine is associated with lower risk of dementia

Pharmacists, REDEEM YOUR CPE HERE!
CPE is available to Health Mart franchise members only
To learn more about Health Mart, click here: https://join.healthmart.com/

CPE Information

Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe dementia's epidemiology and the significance of preventive interventions.
2. Discuss the strengths, weaknesses, and outcomes of the study.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-246-H01-P
Initial release date: 08/19/2024
Expiration date: 08/19/2025
Additional CPE details can be found here.